The German pharmaceutical company Biontech plans to offer data on the inoculation against the coronavirus with its vaccine in children between five and 11 years old at the end of September. The dose for this age group will be 10 micrograms, a third of the adult dose, Özlem Türeci, co-founder of…
Read More...